These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39107366)

  • 1. Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after fecal microbiota transplant in inflammatory bowel disease.
    Zhang YJ; Bousvaros A; Docktor M; Kaplan AL; Rufo PA; Leier M; Weatherly M; Zimmerman L; Nguyen LTT; Barton B; Russell G; Alm EJ; Kahn SA
    Sci Rep; 2024 Aug; 14(1):18188. PubMed ID: 39107366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after Fecal Microbiota Transplant in Inflammatory Bowel Disease.
    Zhang YJ; Bousvaros A; Docktor M; Kaplan A; Rufo PA; Leier M; Weatherly M; Zimmerman L; Nguyen LTT; Barton B; Russell G; Alm EJ; Kahn SA
    medRxiv; 2023 Feb; ():. PubMed ID: 36778473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study.
    van Lingen E; Nooij S; Terveer EM; Crossette E; Prince AL; Bhattarai SK; Watson A; Galazzo G; Menon R; Szabady RL; Bucci V; Norman JM; van der Woude CJ; van der Marel S; Verspaget HW; van der Meulen-de Jong AE; Keller JJ
    J Crohns Colitis; 2024 Sep; 18(9):1381-1393. PubMed ID: 38572716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
    Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
    Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
    Kump P; Högenauer C
    Dig Dis; 2016; 34 Suppl 1():74-81. PubMed ID: 27548724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal transplantation for treatment of inflammatory bowel disease.
    Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
    Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
    Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
    Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease.
    Karolewska-Bochenek K; Grzesiowski P; Banaszkiewicz A; Gawronska A; Kotowska M; Dziekiewicz M; Albrecht P; Radzikowski A; Lazowska-Przeorek I
    Adv Exp Med Biol; 2018; 1047():81-87. PubMed ID: 29151253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
    Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
    Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
    Kong L; Lloyd-Price J; Vatanen T; Seksik P; Beaugerie L; Simon T; Vlamakis H; Sokol H; Xavier RJ
    Gastroenterology; 2020 Dec; 159(6):2193-2202.e5. PubMed ID: 32860788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT)
    Garza-González E; Mendoza-Olazarán S; Morfin-Otero R; Ramírez-Fontes A; Rodríguez-Zulueta P; Flores-Treviño S; Bocanegra-Ibarias P; Maldonado-Garza H; Camacho-Ortiz A
    Can J Gastroenterol Hepatol; 2019; 2019():4549298. PubMed ID: 31976311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Paramsothy S; Paramsothy R; Rubin DT; Kamm MA; Kaakoush NO; Mitchell HM; Castaño-Rodríguez N
    J Crohns Colitis; 2017 Oct; 11(10):1180-1199. PubMed ID: 28486648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbiota transplantation results in bacterial strain displacement in patients with inflammatory bowel diseases.
    Zou M; Jie Z; Cui B; Wang H; Feng Q; Zou Y; Zhang X; Yang H; Wang J; Zhang F; Jia H
    FEBS Open Bio; 2020 Jan; 10(1):41-55. PubMed ID: 31622538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation alters gut phage communities in a clinical trial for obesity.
    Zuppi M; Vatanen T; Wilson BC; Golovina E; Portlock T; Cutfield WS; Vickers MH; O'Sullivan JM
    Microbiome; 2024 Jul; 12(1):122. PubMed ID: 38970126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial.
    Pai N; Popov J; Hill L; Hartung E
    BMJ Open; 2019 Nov; 9(11):e030120. PubMed ID: 31784432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbial transplant for inflammatory bowel disease.
    Claytor JD; El-Nachef N
    Curr Opin Clin Nutr Metab Care; 2020 Sep; 23(5):355-360. PubMed ID: 32618725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease.
    Vaughn BP; Vatanen T; Allegretti JR; Bai A; Xavier RJ; Korzenik J; Gevers D; Ting A; Robson SC; Moss AC
    Inflamm Bowel Dis; 2016 Sep; 22(9):2182-90. PubMed ID: 27542133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.